Prevalence and Molecular Characterization of Pertactin-Deficient Bordetella pertussis in the United States

American Society for Microbiology - Tập 21 Số 2 - Trang 119-125 - 2014
Lucia C. Pawloski1, Anne Marie Queenan2, Pamela K. Cassiday3, Alisson Lynch2, M. J. Harrison3, Wenchi Shang2, Margaret M. Williams3, Katherine E. Bowden3, Brunilis Burgos‐Rivera3, Xuan Qin4, Nancy E. Messonnier3, M. Lucia Tondella3
1Meningitis and Vaccine Preventable Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
2bJanssen Research & Development LLC, Raritan, New Jersey, USA
3Centers for Disease Control & Prevention
4cSeattle Children's Hospital, Seattle, Washington, USA

Tóm tắt

ABSTRACT

Pertussis has shown a striking resurgence in the United States, with a return to record numbers of reported cases as last observed in the 1950s.Bordetella pertussisisolates lacking pertactin, a key antigen component of the acellular pertussis vaccine, have been observed, suggesting thatB. pertussisis losing pertactin in response to vaccine immunity. Screening of 1,300 isolates from outbreak and surveillance studies (historical isolates collected from 1935 up to 2009, isolates from the 2010 California pertussis outbreak, U.S. isolates from routine surveillance between 2010-2012, and isolates from the 2012 Washington pertussis outbreak) by conventional PCR and later by Western blotting andprnsequencing analyses ultimately identified 306 pertactin-deficient isolates. Of these pertactin-deficient strains, 276 were identified as having an IS481in theprngene (prnIS481positive). The firstprnIS481-positive isolate was found in 1994, and the nextprnIS481-positive isolates were not detected until 2010. The prevalence of pertactin-deficient isolates increased substantially to more than 50% of collected isolates in 2012. Sequence analysis of pertactin-deficient isolates revealed various types of mutations in theprngene, including two deletions, single nucleotide substitutions resulting in a stop codon, an inversion in the promoter, and a single nucleotide insertion resulting in a frameshift mutation. All but one mutation type were found inprn2 alleles. CDC 013 was a predominant pulsed-field gel electrophoresis (PFGE) profile in the pertactin-positive isolates (203/994) but was found in only 5% (16/306) of the pertactin-deficient isolates. Interestingly, PFGE profiles CDC 002 and CDC 237 represented 55% (167/306) of the identified pertactin-deficient isolates. These results indicate that there has been a recent dramatic increase in pertactin-deficientB. pertussisisolates throughout the United States.

Từ khóa


Tài liệu tham khảo

Centers for Disease Control and Prevention, 2012, National Notifiable Diseases Surveillance System

Centers for Disease Control and Prevention, 2012, Pertussis epidemic—Washington, 2012, MMWR Morb. Mortal. Wkly. Rep., 61, 517

Clark, 2012, Pertussis control: time for something new?, Trends Microbiol., 20, 211, 10.1016/j.tim.2012.03.003

Misegades, 2012, Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010, JAMA, 308, 2126, 10.1001/jama.2012.14939

Zepp, 2011, Rationale for pertussis booster vaccination throughout life in Europe, Lancet Infect. Dis., 11, 557, 10.1016/S1473-3099(11)70007-X

Rendi-Wagner, 2010, The seroepidemiology of Bordetella pertussis in Israel—estimate of incidence of infection, Vaccine, 28, 3285, 10.1016/j.vaccine.2010.02.104

de Greeff, 2010, Seroprevalence of pertussis in The Netherlands: evidence for increased circulation of Bordetella pertussis, PLoS One, 5, e14183, 10.1371/journal.pone.0014183

Bottero, 2012, Genotypic and phenotypic characterization of Bordetella pertussis strains used in different vaccine formulations in Latin America, J. Appl. Microbiol., 112, 1266, 10.1111/j.1365-2672.2012.05299.x

Bouchez, 2008, Genomic content of Bordetella pertussis clinical isolates circulating in areas of intensive children vaccination, PLoS One, 3, e2437, 10.1371/journal.pone.0002437

Kallonen, 2011, Differences in the genomic content of Bordetella pertussis isolates before and after introduction of pertussis vaccines in four European countries, Infect. Genet. Evol., 11, 2034, 10.1016/j.meegid.2011.09.012

Petersen, 2012, Temporal trends in Bordetella pertussis populations, Denmark, 1949-2010, Emerg. Infect. Dis., 18, 767, 10.3201/eid1805.110812

Schmidtke, 2012, Population diversity among Bordetella pertussis isolates, United States, 1935-2009, Emerg. Infect. Dis., 18, 1248, 10.3201/eid1808.120082

Hegerle, 2012, Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin, Clin. Microbiol. Infect., 18, E340, 10.1111/j.1469-0691.2012.03925.x

Octavia, 2012, Newly emerging clones of Bordetella pertussis carrying prn2 and ptxP3 alleles implicated in Australian pertussis epidemic in 2008-2010, J. Infect. Dis., 205, 1220, 10.1093/infdis/jis178

van Gent, 2012, Small mutations in Bordetella pertussis are associated with selective sweeps, PLoS One, 7, e46407, 10.1371/journal.pone.0046407

Barkoff, 2012, Appearance of Bordetella pertussis strains not expressing the vaccine antigen pertactin in Finland, Clin. Vaccine Immunol., 19, 1703, 10.1128/CVI.00367-12

Bouchez, 2009, First report and detailed characterization of B. pertussis isolates not expressing pertussis toxin or pertactin, Vaccine, 27, 6034, 10.1016/j.vaccine.2009.07.074

Mastrantonio, 1999, Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children, Microbiology, 145, 2069, 10.1099/13500872-145-8-2069

Otsuka, 2012, Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan, PLoS One, 7, e31985, 10.1371/journal.pone.0031985

Queenan, 2013, Pertactin-negative variants of Bordetella pertussis in the United States, N. Engl. J. Med., 368, 583, 10.1056/NEJMc1209369

Winter, 2012, California pertussis epidemic, 2010, J. Pediatr., 161, 1091, 10.1016/j.jpeds.2012.05.041

Mooi, 1998, Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution, Infect. Immun., 66, 670, 10.1128/IAI.66.2.670-675.1998

Mooi, 2000, Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology, Eur. J. Clin. Microbiol. Infect. Dis., 19, 174, 10.1007/s100960050455

Gee, 2003, Use of 16S rRNA gene sequencing for rapid identification and differentiation of Burkholderia pseudomallei and B. mallei, J. Clin. Microbiol., 41, 4647, 10.1128/JCM.41.10.4647-4654.2003

McLafferty, 1988, Nucleotide sequence and characterization of a repetitive DNA element from the genome of Bordetella pertussis with characteristics of an insertion sequence, J. Gen. Microbiol., 134, 2297

Hardwick, 2002, Changes in predominance and diversity of genomic subtypes of Bordetella pertussis isolated in the United States, 1935 to 1999, Emerg. Infect. Dis., 8, 44, 10.3201/eid0801.010021

Cassiday, 2010, Pulsed-field gel electrophoresis profiles of Bordetella pertussis isolated in the United States: comparison between contemporary (2000-2009) and previously reported (1935-1999) strains

Cassiday, 2013, Temporal changes in the predominance of pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates from the United States, 2000

Tatti, 2011, Novel multitarget real-time PCR assay for rapid detection of Bordetella species in clinical specimens, J. Clin. Microbiol., 49, 4059, 10.1128/JCM.00601-11

Stefanelli, 2009, A natural pertactin deficient strain of Bordetella pertussis shows improved entry in human monocyte-derived dendritic cells, New Microbiol., 32, 159

Hellwig, 2003, Crucial role of antibodies to pertactin in Bordetella pertussis immunity, J. Infect. Dis., 188, 738, 10.1086/377283

Henderson, 2004, Type V protein secretion pathway: the autotransporter story, Microbiol. Mol. Biol. Rev., 68, 692, 10.1128/MMBR.68.4.692-744.2004

Bodilis, 2013, Virulence of pertactin-negative Bordetella pertussis isolates from infants, France, Emerg. Infect. Dis., 19, 471, 10.3201/eid1903.121475

van der Ark, 2012, Resurgence of pertussis calls for re-evaluation of pertussis animal models, Expert Rev. Vaccines, 11, 1121, 10.1586/erv.12.83

Thông tin
Thông tin xuất bản

American Society for Microbiology

Tập 21 Số 2

119-125

Thông tin tác giả